home / stock / wint / wint articles

WINT Articles, Windtree Therapeutics Inc.

Stock Information
Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Menu
WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Windtree Therapeutics (WINT) Stock Is Getting Hammered | Benzinga

Windtree Therapeutics Inc (NASDAQ:WINT) shares are trading lower by 20% to $0.32 during Thursday’s session after the company announced it app...
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday's session despite better-than-expected first-quarter results. The comp...

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing | Benzinga

WARRINGTON, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), today announced ...

Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company | Benzinga

Windtree Therapeutics (NASDAQ: WINT) announced an agreement with affiliates of biopharma investor Deerfield Management Company to fully retire a $1...
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company | Benzinga

WARRINGTON, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology c...

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China | Benzinga

Greater China holds a significant, if not the world’s largest, acute heart failure patient population. It may be a market where drug treatmen...

Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator | Benzinga

Arrhythmias are irregular heartbeats that can impact the pumping function of the heart. Patients with heart failure and cardiomyopathy are at risk ...
Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock | Benzinga

SEISMiC Extension Study results are anticipated in mid-2024 and expected to provide dose optimization for Phase 3 The Company is also progressing...

Windtree to Present at the Sidoti Micro Cap Conference on November 16th | Benzinga

WARRINGTON, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology c...

Windtree to Present at the ThinkEquity Conference on October 19th in New York City | Benzinga

WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology c...
Next 10